Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-24 @ 9:24 PM
NCT ID:
NCT07282132
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of Polycythemia Vera according to updated diagnostic criteria
* Have received at least one dose of Ropeginterferon Alfa-2b (BESREMI).
* Complete clinical and laboratory data availability for review (e.g., hematologic parameters, treatment response, adverse events).
* Followed at one of the participating study centers.
* Have signed informed consent for participation.
Exclusion Criteria:
* Have received experimental or non-approved treatments for PV during the observation period.
* Lack sufficient clinical or laboratory data to allow inclusion in the analysis.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07282132
Study Brief:
Protocol Section:
NCT07282132